Advanced diagnostics Eurofins Biomnis is a European leader in specialized medical pathology with a strong focus on advanced techniques such as LC-MS/MS and molecular genetics, presenting a sales opportunity to expand offerings in toxin detection, clinical research, and personalized medicine.

High throughput With over 32,000 analyses per day and more than 2,500 tests available, there is potential to upsell automation, streamlined workflow solutions, and scalable testing partnerships to support growing demand and international expansion.

Innovation emphasis Continuous investment in female biology, oncology, biobanking, and clinical research infrastructure suggests opportunities to propose new assay development, validation services, and collaborative studies aligned with cutting-edge diagnostics.

Clinical research capacity Strong clinical research and biobanking capabilities position Eurofins Biomnis as a potential partner for biorepositories, longitudinal studies, and translational research projects requiring specialized pathology support.

International expansion As a core part of Europe’s Clinical Diagnostics division with eyes on international development, there is a sales opening to offer cross-border laboratory services, harmonized testing panels, and global logistics partnerships for multinational clients.